Simplex Trading, LLC Orchard Therapeutics PLC Transaction History

Simplex Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$0.45 - $0.69 $450 - $690	1,000 Added 114.94%	1,870 $0
Q2 2022 Aug 03, 2022	BUY	$0.42 - $0.78 $365 - $678	870 New	870 $0
Q1 2022 May 02, 2022	SELL	$0.7 - $1.51 $12,441 - $26,837	-17,773 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$1.16 - $2.23 $48,072 - $92,415	-41,442 Reduced 69.99%	17,773 $23,000
Q2 2021 Aug 12, 2021	BUY	$4.39 - $7.23 $192,075 - $316,334	43,753 Added 282.97%	59,215 $259,000
Q1 2021 Apr 26, 2021	BUY	$4.39 - $9.08 $4,670 - $9,661	1,064 Added 7.39%	15,462 $112,000
Q4 2020 Feb 02, 2021	BUY	$3.86 - $5.07 $50,261 - $66,016	13,021 Added 945.61%	14,398 $62,000
Q3 2020 Oct 14, 2020	BUY	$4.11 - $6.45 $5,162 - $8,101	1,256 Added 1038.02%	1,377 $5,000
Q2 2020 Jul 13, 2020	BUY	$5.75 - $11.99 $695 - $1,450	121 New	121 $0

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.